Adalimumab trough levels of 4.0 mg/L or higher among patients with RA were linked to greater treatment response and ...
Patients with rheumatoid arthritis who demonstrate consistent long-term elevation of inflammatory markers have an increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback